Early is Good

Early is Good Develops Kidney Disease Diagnostic Products; Its First Product, BCDx, is a Laboratory-Developed Method for Early Detection of Bladder Cancer. The BCDx Test Uses Nanotechnology to Quantify a Set of Biomarkers Found in Patient Urine to Diagnose Bladder Cancer and Determine the Stage of the Disease.